Evidence map›Paper›PMID 25102452›Full record

ArticleBrain, behavior, and immunity2015

Tumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function.

Diana M Norden, Sabahattin Bicer, Yvonne Clark, Runfeng Jing, Christopher J Henry, Loren E Wold, Peter J Reiser, Jonathan P Godbout, Donna O McCarthy

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Trial
  3. Review
  4. Brain Metabolic Activity Measured by [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  5. Article
  6. Review
  7. The Significance of CXCL1 in Cancer: An Overview of Molecular Mechanisms.International journal of molecular sciences · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. The metabolic basis of cancer-related fatigue.Neuroscience and biobehavioral reviews · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Microglia contribute to mammary tumor-induced neuroinflammation in a female mouse model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  18. Effects of acteoside fromFrontiers in pharmacology · 2024
    Article
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Diana M NordenDepartment of Neuroscience, The Ohio State University, 333 W. 10th Ave., Columbus, OH 43210, United States.
Sabahattin BicerDivision of Biosciences, College of Dentistry, The Ohio State University, 305 W. 12th Ave., Columbus, OH, United States.
Yvonne ClarkCollege of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, United States.
Runfeng JingCollege of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, United States.
Christopher J HenryDepartment of Neuroscience, The Ohio State University, 333 W. 10th Ave., Columbus, OH 43210, United States.
Loren E WoldCollege of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, United States; Department of Physiology and Cell Biology, The Ohio State University, 370 W. 9th Ave., Columbus, OH, United States.
Peter J ReiserDivision of Biosciences, College of Dentistry, The Ohio State University, 305 W. 12th Ave., Columbus, OH, United States.
Jonathan P GodboutDepartment of Neuroscience, The Ohio State University, 333 W. 10th Ave., Columbus, OH 43210, United States; Institute for Behavioral Medicine Research, The Ohio State University, 460 Medical Center Dr., Columbus, OH, United States.
Donna O McCarthyCollege of Nursing, The Ohio State University, 1585 Neil Ave., Columbus, OH, United States. Electronic address: donnalee.mccarthy@mu.edu.
The Ohio State University · USInstitute for Behavioral Medicine · US

Funding

Muscle function and depression-like behavior in a mouse model of cancer fatigueR01NR012618 · NINR · OHIO STATE UNIVERSITY · PI REISER, PETER J, WOLD, LOREN EUGENE · 2012 to 2016
$2.2M
Synergistic effects of obesity and air pollution on cardiac functionR01ES019923 · NIEHS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WOLD, LOREN EUGENE · 2011 to 2015
$1.8M
Aging, Microglial Dysregulation and DepressionR01AG033028 · NIA · OHIO STATE UNIVERSITY · PI GODBOUT, JONATHAN P · 2009 to 2013
$1.5M
NIA NIH HHS R01 AG033028NIA NIH HHS R01-AG-033028NIEHS NIH HHS R01 ES019923NINR NIH HHS R01 NR012618NINR NIH HHS R01-NR-012618
6 · The paper itself

Abstract

Cancer patients frequently suffer from fatigue, a complex syndrome associated with loss of muscle mass, weakness, and depressed mood. Cancer-related fatigue (CRF) can be present at the time of diagnosis, during treatment, and persists for years after treatment. CRF negatively influences quality of life, limits functional independence, and is associated with decreased survival in patients with incurable disease. Currently there are no effective treatments to reduce CRF. The aim of this study was to use a mouse model of tumor growth and discriminate between two main components of fatigue: loss of muscle mass/function and altered mood/motivation. Here we show that tumor growth increased fatigue- and depressive-like behaviors, and reduced body and muscle mass. Decreased voluntary wheel running activity (VWRA) and increased depressive-like behavior in the forced swim and sucrose preference tests were evident in tumor-bearing mice within the first two weeks of tumor growth and preceded the loss of body and muscle mass. At three weeks, tumor-bearing mice had reduced grip strength but this was not associated with altered expression of myosin isoforms or impaired contractile properties of muscles. These increases in fatigue and depressive-like behaviors were paralleled by increased expression of IL-1β mRNA in the cortex and hippocampus. Minocycline administration reduced tumor-induced expression of IL-1β in the brain, reduced depressive-like behavior, and improved grip strength without altering muscle mass. Taken together, these results indicate that neuroinflammation and depressed mood, rather than muscle wasting, contribute to decreased voluntary activity and precede major changes in muscle contractile properties with tumor growth.

Indexed as

AdenocarcinomaAnimalsBehavior, AnimalColonic NeoplasmsDepressionDisease Models, AnimalDisease ProgressionFatigueFemaleMiceMotor ActivityMuscle, SkeletalNeoplasm TransplantationQuality of LifeCancerCytokinesDepressionFatigueMinocyclineNeuroinflammation

Identifiers

PMID25102452
PMCPMC4258420
OpenAlexW2000515779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.